Congressional record
David Taylor bought Amgen Inc. stock on JUN 5.
David Taylor — a trade near an FDA decision
The FDA recorded a recall (Class II) of a product from Amgen Inc. on JUN 4.
1 day separated the trade and the FDA action.
9 of Taylor's disclosed trades fall within three weeks of an FDA decision.
Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
SOURCE: STOCK ACT DISCLOSURES, HOUSE CLERK · OPENFDA, U.S. FOOD & DRUG ADMINISTRATION
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.
Browse the record:
All bills analysed by Quorum · Every member of Congress · Who funds them · Latest findings